|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
10/24/2006 11:24:52 AM
NEW YORK--(BUSINESS WIRE)--Medidata Solutions, a global provider of electronic clinical data capture, management and reporting solutions, today announced that Daiichi Pharmaceutical Co., Ltd. has chosen Medidata Rave for its ability to efficiently and cost-effectively manage multilingual clinical trials, and ultimately bring life-enhancing treatments to market faster. As Medidata Solutions’ first customer in the Japan market, Daiichi has successfully implemented six clinical trials, including a Phase II, 500-patient, 60-site study for a cardiovascular drug. Daiichi plans to continue to use Medidata Rave for additional Phase I, Phase II and Phase III studies in other therapeutic areas.
|
|
|
|
|
|
|
|
|
|
|